Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chi Leong Chio"'
Autor:
Cunte Chen, Chaofeng Liang, Shunqing Wang, Chi Leong Chio, Yuping Zhang, Chengwu Zeng, Shaohua Chen, Caixia Wang, Yangqiu Li
Publikováno v:
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-5 (2020)
Abstract Immunotherapy with immune checkpoint inhibitors (ICIs) for solid tumors had significantly improved overall survival. This type of therapy is still not available for acute myeloid leukemia (AML). One major issue is the lack of knowledge for t
Externí odkaz:
https://doaj.org/article/a059f9c84db34eea94bbc07768fa6857
Autor:
Cunte Chen MD, Zhuowen Chen MD, Chi Leong Chio MD, Ying Zhao MD, Yongsheng Li MM, Zhipeng Liu MM, Zhenyi Jin MD, Xiuli Wu MD, Wei Wei PhD, Qi Zhao PhD, Yangqiu Li MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 20 (2021)
Background: Cytogenetics at diagnosis is the most important prognostic factor for adult acute myeloid leukemia (AML), but nearly 50% of AML patients who exhibit cytogenetically normal AML (CN-AML) do not undergo effective risk stratification. Therefo
Externí odkaz:
https://doaj.org/article/a692c929daee4ec78762d83b04da202e
Autor:
Qi Zhao, Cunte Chen, Zhenyi Jin, Yangqiu Li, Zhuowen Chen, Ying Zhao, Wei Wei, Chi Leong Chio, Xiuli Wu, Zhipeng Liu, Yongsheng Li
Publikováno v:
Technology in Cancer Research & Treatment
Background: Cytogenetics at diagnosis is the most important prognostic factor for adult acute myeloid leukemia (AML), but nearly 50% of AML patients who exhibit cytogenetically normal AML (CN-AML) do not undergo effective risk stratification. Therefo
Publikováno v:
Hematology (Amsterdam, Netherlands). 26(1)
Previous study (A total of 262 bone marrow transcriptomic data of IR-AML in the GSE12417-GPL96 and GSE71014-GPL-10558 from the Gene Expression Omnibus database (GEO) database, and 92 IR-AML patients from the cancer genome atlas (TCGA) database were o
Autor:
Caixia Wang, Cunte Chen, Shunqing Wang, Chi Leong Chio, Chaofeng Liang, Chengwu Zeng, Yuping Zhang, Yangqiu Li, Shaohua Chen
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-5 (2020)
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-5 (2020)
Immunotherapy with immune checkpoint inhibitors (ICIs) for solid tumors had significantly improved overall survival. This type of therapy is still not available for acute myeloid leukemia (AML). One major issue is the lack of knowledge for the expres
Autor:
Yangqiu Li, Cunte Chen, Chaofeng Liang, Shunqing Wang, Chi Leong Chio, Yuping Zhang, Chengwu Zeng, Shaohua Chen, Caixia Wang
Publikováno v:
Experimental Hematology. 88:S70
Background Immunotherapy with immune checkpoint inhibitors (ICIs) for solid tumors had significantly improved overall survival. This type of therapy has not been evaluated well in acute myeloid leukemia (AML), and basic information on immune checkpoi